B cell Select

B cell Select

Discovery Services
B cell Select
B cell Select

Information

Our proprietary B cell screening, sorting, and sequencing technology increases the speed of antibody discovery, maintains native antibody pairing, provides antibodies of higher sensitivity and specificity and is applicable to any protein class, including complex therapeutic targets. Combining this technology with, for example, OmniAb® animals offers a truly unique and superior antibody discovery option not found elsewhere.
Link
https://www.immunoprecise.com/discovery/
ImmunoPrecise AntibodiesImmunoPrecise is an international, full-service, therapeutic antibody discovery company offering species agnostic advancements such as the B cell SelectTM progressive, single-cell interrogation technology and the DeepDisplayTM custom phage libraries, as well as the AbthenaTM bispecific program. IPA is focused on the next generation of antibody discovery, to deliver the most therapeutically relevant antibodies, in a shorter period of time, with the highest probability of succeeding to clinical trials. ImmunoPrecise’s discovery and development are conducted in Utrecht and Oss, the Netherlands (U-Protein Express and IPA Europe, respectively), and in Victoria, British Columbia (IPA Canada). The Company operates globally to offer a continuum of superior antibody services, transforming the face of therapeutic discovery, by decreasing turnaround time and risk, and promoting clinical success.

Log in